Brain cancer trial aims to delay tumor return by zapping stem cells
NCT ID NCT02177578
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tests whether giving a higher radiation dose to a specific brain area (the subventricular zone) alongside standard radiation and chemotherapy can delay glioblastoma from coming back. About 60 adults with newly diagnosed glioblastoma will be randomly assigned to receive either the modified radiation or standard treatment. The goal is to see if targeting this stem-cell-rich region improves tumor control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
-
Suburban Hospital
Bethesda, Maryland, United States
-
The SKCCC at Johns Hopkins
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.